Image 1
Chemical structure diagram of the active ingredient Norethindrone Acetate, showing its steroid backbone and functional groups.*
Loestrin Kit
Product Images NDC 51285-128
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Loestrin (NDC 51285-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Women's Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Clinic Use Only, Loestrin® Fe 1.5/30 (norethindrone Acetate And Ethinyl Estradiol Tablets Usp And Ferrous Fumarate Tablets*) 28 Day Regimen, 30 Blister Cards, 28 Tablets Each, Carton, Part 1 Of 2 (Image 10)
Illustration of a 28-day Loestrin 1/20 oral tablet blister pack layout indicating day and week directions for pill intake. It includes labeled rows for weeks 1 to 4 and days Sunday to Saturday, instructions for both Sunday and Day-1 starters, and guidance to take pills left to right each week. The diagram highlights active and inactive pills in the weekly sequence.*
Clinic Use Only, Loestrin® Fe 1.5/30 (norethindrone Acetate And Ethinyl Estradiol Tablets Usp And Ferrous Fumarate Tablets*) 28 Day Regimen, 30 Blister Cards, 28 Tablets Each, Carton, Part 2 Of 2 (Image 11)
An instructional diagram for Loestrin 21 Day 1.5 mg/30 mcg tablets showing a 28-day pill pack layout. It includes labeled rows for four weeks and columns for days Sunday through Saturday. Arrows indicate starting points for Sunday and Day-1 starters, with instructions to take pills left to right each week. The image highlights the proper sequence for oral contraceptive use.*
Loestrin 21 1/20 Blister Image (Image 12)
Packaging label for Loestrin 21/20 tablets containing norethindrone acetate and ethinyl estradiol. The label shows the 21-day regimen oral tablet package by Teva Women's Health LLC, featuring a fold-out design with dosage and labeling information visible on multiple panels.*
Loestrin 21 1.5/30 Blister Image (Image 13)
Packaging label for Loestrin Fe 1/20 tablets, an oral contraceptive containing norethindrone acetate and ethinyl estradiol. The label indicates a 28-day regimen and displays the strength as 1/20 in large text. The labeler is Teva Women's Health LLC.*
Loestrin Fe 1/20 Blister Image (Image 14)
Packaging label for Loestrin 21 1.5/30 oral tablets. The label shows the brand name Loestrin 21 1.5/30, indicating the combination of norethindrone acetate and ethinyl estradiol, with a 21-day dosing regimen. The labeler is Teva Women's Health LLC. The label is designed for a carton, including barcodes and dosage details.*
Loestrin Fe 1.5/30 Blister Image (Image 15)
Flat packaging label for Loestrin Fe 1.5/30 tablets by Teva Women's Health LLC. The label indicates oral tablets containing norethindrone acetate and ethinyl estradiol with strengths 1.5 mg and 30 mcg respectively. The packaging is designed for a 28-day regimen and displays dosage and tablet count information.*
Loestrin 21 1/20 Blister Image (Image 16)
Packaging label for Loestrin Fe 1/20 tablets, containing norethindrone acetate and ethinyl estradiol with ferrous fumarate. This oral tablet product is for clinic use, supplied in a 30-unit package with a 28-day regimen. Labeler is Teva Women's Health LLC. Barcodes and regulatory text are present on the label.*
Loestrin 21 1.5/30 Blister Image (Image 17)
Packaging label for Loestrin Fe 1/20 tablets, oral contraceptive containing norethindrone acetate and ethinyl estradiol, plus ferrous fumarate tablets. This 28-day regimen package contains 30 units and is labeled for clinic use only. The label also includes storage instructions and the manufacturer, Teva Women's Health LLC.*
Loestrin Fe 1/20 Blister Image (Image 18)
Packaging label for Loestrin Fe 1.5/30 tablets, containing norethindrone acetate and ethinyl estradiol USP with ferrous fumarate tablets. The label indicates a 28-day regimen with 30 units per package. It is labeled for clinic use only and distributed by Teva Women's Health LLC.*
Loestrin Fe 1.5/30 Blister Image (Image 19)
Packaging label for Loestrin Fe 1.5/30 tablets, containing norethindrone acetate and ethinyl estradiol with ferrous fumarate. This 28-day regimen oral tablet product is labeled for clinic use only and comes in a package of 30 units. The labeler is Teva Women's Health LLC.*
Image 2
Chemical structure diagram of Ethinyl Estradiol, a component of Loestrin 21 Day tablets, showing its steroid nucleus and functional groups including hydroxyl and ethynyl substituents.*
Image 3
A bar graph titled 'Table II Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' It shows mortality rates for age groups 15-24, 25-34, 35-44, and 45+ comparing four groups: ever-users non-smokers, ever-users smokers, controls non-smokers, and controls smokers. Mortality rates increase notably with age, especially for ever-users smokers.*
Image 4
An instructional diagram showing a 21-day blister pack for Loestrin 21 Day oral tablets, labeled with days of the week from Sunday to Saturday across three rows representing each week. Arrows and text guide users to start according to Sunday or Day-1 starter methods, indicating pill-taking direction from left to right across each week. The pack is marked Teva and includes storage instructions.*
Image 5
An instructional diagram showing the day and week layout for Loestrin 21 Day oral tablets. It includes arrows indicating the start points for Sunday and Day-1 starters, labeling for three weeks of dosing, and direction arrows to take pills from left to right each week. The tablet push-through card layout is clearly depicted with day names (SUN to SAT) and the dosage information printed on the card.*
Image 6
An illustrated medication guide showing a 28-day Loestrin 1/20 tablet pack with weekly rows labeled week 1 through week 4 and days Sunday through Saturday. It includes instructions for Day-1 starters and Sunday starters on where to begin taking pills. Directions indicate taking pills from left to right each week, with the last row pills shaded differently to represent inactive tablets.*
Image 7
An instructional diagram showing the dosing schedule for Loestrin 21 Day tablets. It displays a 28-day pill strip with four rows labeled Week 1 to Week 4, and columns labeled with days of the week from Sunday to Saturday. The image indicates starting points for Sunday starters and Day-1 starters and directions to take pills from left to right each week.*
Image 8
An instructional diagram for Loestrin 21 Day oral tablets showing a weekly pill pack layout with rows labeled Week 1, Week 2, and Week 3 and columns labeled Sunday through Saturday. Arrows and text guide users to start on Sunday or day 1 of their period and to take pills from left to right each week. The pack is labeled with strength 1/20 and manufactured by Teva.*
Image 9
An instructional diagram showing the pill pack layout for Loestrin 21 Day tablets, featuring three rows labeled Week 1, Week 2, and Week 3. There are columns for days of the week from Sunday to Saturday. Arrows indicate starting points for Sunday starters and Day-1 starters and guide pill-taking direction from left to right each week. The pill pack includes storage instructions and the product name with active ingredients noted.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
